Overview A Long-term Safety Study of QVM149 in Japanese Patients With Asthma Status: Completed Trial end date: 2019-04-08 Target enrollment: Participant gender: Summary The purpose of this study is to provide long term safety data of QVM149 in Japanese patients with asthma for the registration of QVM149 in Japan. Phase: Phase 3 Details Lead Sponsor: Novartis Pharmaceuticals